Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon.

Haemostasis, 01 Jan 1980, 9(6):325-344
https://doi.org/10.1159/000214375 PMID: 7005035

Abstract

No abstract provided.

Full text links

Read article at publisher's site: https://doi.org/10.1159/000214375

Citations & impact

Impact metrics

39

Citations

Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/170529383

Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/170529383

Article citations

Plasminogen activators and ischemic stroke: conditions for acute delivery.
del Zoppo GJ
Semin Thromb Hemost, 39(4):406-425, 28 Mar 2013
Cited by: 2 articles | PMID: 23539414 | PMCID: PMC3703437
Review Free full text in Europe PMC
Physicians' attitudes toward post-MI aspirin prophylaxis: findings from an online questionnaire in Europe and Latin America.
Zaninelli A, Kaufholz C, Schwappach D
Postgrad Med, 121(6):44-53, 01 Nov 2009
Cited by: 8 articles | PMID: 19940416
Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Schulman S, Beyth RJ, Kearon C, Levine MN
Chest, 133(6 suppl):257S-298S, 01 Jun 2008
Cited by: 332 articles | PMID: 18574268
Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S
Chest, 126(3 suppl):287S-310S, 01 Sep 2004
Cited by: 239 articles | PMID: 15383476
Review
[Secondary prevention of acute myocardial infarction: should oral anticoagulants and platelet antiaggregants be administered on a combined basis?].
Fortuny J, Agustí A
Med Clin (Barc), 121(11):433-435, 01 Oct 2003
Cited by: 0 articles | PMID: 14563277
Review

Go to all (39) article citations

Similar Articles

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
Breddin K, Loew D, Lechner K, Oberla K, Walter E
Circulation, 62(6 pt 2):V63-72, 01 Dec 1980
Cited by: 22 articles | PMID: 6777073
[Prevention of sequelae after myocardial infarct. Results, methods and problems of a prospective multi-center study of the effect of acetylsalicylic acid, phenprocoumon and placebo].
Breddin HK, Uberla KK
Verh Dtsch Ges Inn Med, 86:1338-1348, 01 Jan 1980
Cited by: 0 articles | PMID: 7013326
Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.
Breddin K, Loew D, Lechner K, Uberla K, Walter E
Thromb Haemost, 41(1):225-236, 01 Feb 1979
Cited by: 23 articles | PMID: 483232
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Schröder R
Dtsch Med Wochenschr, 106(17):546-553, 01 Apr 1981
Cited by: 0 articles | PMID: 6111439
Review